Patents for A61P 35 - Antineoplastic agents (221,099)
09/2008
09/03/2008CN101255152A Preparation method and use of piperazine having cytotoxic activity
09/03/2008CN101255146A 5/7/6 type 13(15) site epoxy taxane diterpenoid, medicament combination and uses thereof
09/03/2008CN101255139A Method for synthesizing antitumor compound of diketopiperazine PJ147
09/03/2008CN101255124A Cinnamide histone deacetylase inhibitor and preparation method thereof
09/03/2008CN101255121A Preparation technique of lysine rhein and use thereof in tumour therapy
09/03/2008CN101255119A Novel tetrahydro curcumin derivatives and salt
09/03/2008CN101255103A Marine penicillium antitumor reactive compound as well as preparation method and utilization thereof
09/03/2008CN101254309A Folacin receptor mediated targeted acetyl pullulan polysaccharide nano granule and preparation thereof
09/03/2008CN101254308A Biogastrone acid-polyethyleneglycol /chitosan liver target composite drug administration system and preparation thereof
09/03/2008CN101254303A Cytotoxicity mediation of cells evidencing surface expression of MCSP
09/03/2008CN101254301A Preparation of HSP65 recombination protein and use thereof
09/03/2008CN101254269A Cancer treating medical composition, preparation and uses thereof
09/03/2008CN101254240A Gene therapy for radically treating hepatitis B
09/03/2008CN101254234A Antineoplastic Chinese medicinal composition of supercritical bee glue, ganoderma lucidum sporule oil and perilla oil
09/03/2008CN101254233A Gene therapy for radical curing SARS respiratory disease
09/03/2008CN101254217A Preparation of extract of regeneratabl portion of yew and applications of same for preparing oral anti-cancer medicine
09/03/2008CN101254209A Calf spleen extract injection prepared by inphase opposition column chromatography and preparation thereof
09/03/2008CN101254205A Pd complex compound of carbohydrates derivative, preparing method thereof and applications of complex compound for curing cancer
09/03/2008CN101254204A Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors
09/03/2008CN101254193A Therapeutic hpph dosage for pdt
09/03/2008CN101254188A Use of medicament of geldanamycin derivative for preparing medicament for curing chemotherapy induction alopecia
09/03/2008CN101254183A Novel use of niclosamide and pharmaceutically acceptable salt thereof
09/03/2008CN101254173A Soluble semen iris lacteae powder preparations and method of preparing the same
09/03/2008CN101254170A An anticancer sustained release injection carrying clorfarabine and its synergist
09/03/2008CN101254166A An anticancer sustained release injection carrying clorfarabine and its synergist
09/03/2008CN100415895C Non-splicing variant of gp 350/220
09/03/2008CN100415772C Anti-ErbB2 antibodies
09/03/2008CN100415770C 2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}- alkylboronic acid derivatives
09/03/2008CN100415753C 4-dimethylamino crotonic acid, its derivatives and their preparing method
09/03/2008CN100415747C Phosphodiesterase 4 inhibitors
09/03/2008CN100415740C Pyrimidine compounds
09/03/2008CN100415724C Pyrimidine derivatives
09/03/2008CN100415720C Quinoline derivative and quinazoline derivative, and medicinal composition containing the same
09/03/2008CN100415719C 2,5-disubstituted 3-mercaptopentanoic acid
09/03/2008CN100415718C CASPASE inhibitors and use thereof
09/03/2008CN100415298C Adenovirus vector for idiopathy liver genetherapy and using method
09/03/2008CN100415292C New class of bioactive glycoprotein
09/03/2008CN100415283C Medicine for resisting inflammation, contracting uterus and eliminating tumor and its preparation process
09/03/2008CN100415282C Paste for treating cancers
09/03/2008CN100415272C Medicated liquid for male to health-preserving and prolonging life
09/03/2008CN100415267C Use of fritillaria alkaloid extract in preparation of medicine for treating tumor
09/03/2008CN100415264C Medicated liquid for female health preserving and prolonging life
09/03/2008CN100415258C Chinese traditional medicine composition for treating leucopenia and preparation and quality controlling method thereof
09/03/2008CN100415242C Drop pills of vepeside and preparation process thereof
09/03/2008CN100415236C Cancer combination therapy comprising AZD217 and ZD1839, medicament box, and pharmaceutical use of AZD2171 and ZD1839
09/03/2008CN100415231C Osmotic pump type controlled release preparation of kurarinone and its preparing method
09/03/2008CN100415228C Medicine containing galangin and preparation method thereof
09/03/2008CN100415221C Curcumin lyophilized liposome for injection and its preparing method
09/03/2008CN100415219C Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients
09/02/2008US7420066 Benzofuran derivatives useful for treating hyper-proliferative disorders
09/02/2008US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
09/02/2008US7420045 IAPs associated cell cycle proteins, compositions and methods of use
09/02/2008US7420042 Soluble neuropilin/growth factor receptor fusion proteins
09/02/2008US7420037 Heat shock protein-based vaccines and immunotherapies
09/02/2008US7420034 Of given sequence; human leukocyte antigen; induce cytotoxic T cells; use in vaccines
09/02/2008US7420003 Compounds and a novel process for their preparation
09/02/2008US7419998 Therapeutic methods and compositions involving isoflavones
09/02/2008US7419993 Triazolo-epothilones
09/02/2008US7419977 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2- alpha ]quinoline-2-carbonyl)morpholine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives
09/02/2008US7419968 Screening for anticancer drugs for treating cells that endogenously overexpress intracellular thymidylate synthase by contacting the cell with the candidate and (E)-5-(2-bromovinyl)-2'-deoxy-5'-uridyl phenyl L-alaninylphosphoramidate and assaying for cell death
09/02/2008US7419956 Isolated physiologically active peptide and use thereof
09/02/2008US7419814 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/02/2008US7419804 CASH (Caspase Homologue) with death effector domain, modulators of the function of FAS
09/02/2008US7419794 Antibodies specific for CYP1B1
09/02/2008US7419792 Detecting binding of said antigen in tissue sample; treating cells to aid in differentiation, treatment and diagnostic imaging
09/02/2008US7419790 Sodium-independent transporter carrying acidic amino acid and its gene
09/02/2008US7419669 Peptide epitopes common to antigens of the same multigene family
09/02/2008US7419667 Drug for cancer therapy
09/02/2008US7419660 Isolating nucleic acid from malignant cells, inserting into expression vector, transformation; light regions differ by one idiotope
09/02/2008CA2389333C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
09/02/2008CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf
09/02/2008CA2351665C Antagonistic analogs of gh-rh inhibiting igf-i and -ii
09/02/2008CA2325818C Topical immunostimulation to induce langerhans cell migration
09/02/2008CA2318848C 5'-deoxycytidine derivatives
09/02/2008CA2314238C Synthesis of combretastatin a-4 prodrugs and trans-isomers thereof
09/02/2008CA2311486C Crystalline amrubicin hydrochloride
09/02/2008CA2294351C Compounds useful for inhibition of farnesyl protein transferase
09/02/2008CA2276269C N-acyl phosphatidylethanolamine-mediated liposomal drug delivery
09/02/2008CA2246430C Protein tyrosine phosphatases of hematopoietic cells
09/02/2008CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent
09/02/2008CA2131662C Improved prodrugs for enzyme mediated activation
08/2008
08/28/2008WO2008103905A2 Antibodies that specifically bind irta and methods of use
08/28/2008WO2008103755A1 Treating cancer with viral nucleic acid
08/28/2008WO2008103693A2 Chemical linkers with single amino acids and conjugates thereof
08/28/2008WO2008103636A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors
08/28/2008WO2008103431A2 Dnai - liposomes
08/28/2008WO2008102888A1 Novel pseudoglycolipid and use thereof
08/28/2008WO2008102881A1 ANALOGUE OF MAPKK NUCLEAR EXPORT INHIBITOR peumusolide A AND USE THEREOF
08/28/2008WO2008102870A1 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
08/28/2008WO2008102749A1 Heterocyclic compound
08/28/2008WO2008102669A1 Novel sugar-linked chlorin derivative and process for production thereof
08/28/2008WO2008102557A1 Peptide vaccines for cancers expressing tumor-associated antigens
08/28/2008WO2008102374A1 Amorphous form of docetaxel
08/28/2008WO2008102369A1 Novel polymorphs of erlotinib hydrochloride and method of preparation
08/28/2008WO2008102350A1 Isoflavone derivatives and uses thereof
08/28/2008WO2008102233A1 Integrin targeted cyclopeptide ligands, their preparation and use
08/28/2008WO2008102075A2 Novel therapeutic use for treating leukaemia
08/28/2008WO2008101979A1 Quinoxaline compounds and use thereof
08/28/2008WO2008101951A1 Combination therapy using tnf and alfa-galactosyl ceramide
08/28/2008WO2008101469A2 Pharmaceutical preparation for treating metastases